Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 5.36 % |
3 Month Return | + 34.67 % |
1 Year Return | + 90.79 % |
Market Stats | |
Previous Close | ₹156.35 |
Open | ₹160.00 |
Volume | 2,772.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹184.92Cr |
P/E Ratio | 15.19 |
PEG Ratio | 10.13 |
Market Cap | ₹184.92 Cr |
P/B Ratio | 7.03 |
EPS | 8.38 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 6.54 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹184.92 Cr | 174.83% | 0.50 | ₹9 Cr | ₹188 Cr | |
NA | ₹435.76 Cr | 272.24% | 0.54 | ₹28 Cr | ₹601 Cr | |
NA | ₹15.41 Cr | 278.33% | 0.50 | NA | NA | |
BUY | ₹23,100.09 Cr | 3.59% | 0.52 | NA | NA | |
NA | ₹706.49 Cr | -0.07% | 0.57 | ₹9 Cr | ₹179 Cr |
Organisation | Parnax Lab Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Parnax Lab Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
In the last 1 year, Parnax Lab has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Best in 3 Years
In the last 3 years, Parnax Lab has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 27.70% of holdings in Sep 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 72.30% of holdings in Sep 2024 quarter
Price Dip
In the last 7 days, Parnax Lab stock has moved down by -4.6%
Profit Down
Netprofit is down for the last 2 quarters, 3.98 Cr → 3.41 Cr (in ₹), with an average decrease of 14.3% per quarter
Revenue Fall
Revenue is down for the last 2 quarters, 50.23 Cr → 49.31 Cr (in ₹), with an average decrease of 1.8% per quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 72.3% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 27.7% | 0.00 | |
Others | 0% | 0.00 |
Parnax Lab Ltd in the last 5 years
Lowest (-82.38x)
May 26, 2021
Today (15.19x)
December 19, 2024
Industry (56.23x)
December 19, 2024
Highest (177.62x)
February 9, 2021
Parnax Lab Ltd’s net profit jumped 82.35% since last year same period to ₹3.41Cr in the Q2 2024-2025. On a quarterly growth basis, Parnax Lab Ltd has generated -14.32% fall in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Parnax Lab Ltd is currently in a Bullish trading position according to technical analysis indicators.
Parnax Lab Ltd (506128) share price today is ₹161.4
Parnax Lab Ltd is not listed on NSE
Parnax Lab Ltd is listed on BSE
PE Ratio of Parnax Lab Ltd is 15.19
PE ratio = Parnax Lab Ltd Market price per share / Parnax Lab Ltd Earnings per share
Today’s traded volume of Parnax Lab Ltd(506128) is 2,772.00.
Today’s market capitalisation of Parnax Lab Ltd(506128) is ₹184.92Cr.
Parnax Lab Ltd(506128 | Price |
---|---|
52 Week High | ₹193.5 |
52 Week Low | ₹80.41 |
Parnax Lab Ltd(506128) share price is ₹161.4. It is down -16.59% from its 52 Week High price of ₹193.5
Parnax Lab Ltd(506128) share price is ₹161.4. It is up 100.72% from its 52 Week Low price of ₹80.41
Parnax Lab Ltd(506128 | Returns |
---|---|
1 Day Returns | 5.05% |
1 Month Returns | 5.36% |
3 Month Returns | 34.67% |
1 Year Returns | 90.79% |